Skip to main content
Erschienen in: Digestive Diseases and Sciences 7/2011

01.07.2011 | Original Article

Successful Control of Peristomal Infection by Introducer-Type Percutaneous Endoscopic Gastrostomy: A Retrospective Historical Control Study

verfasst von: Chul-Hyun Lim, Jae Myung Park, Yu Kyung Cho, In Seok Lee, Sang Woo Kim, Myung-Gyu Choi, In-Sik Chung

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

The techniques of percutaneous endoscopic gastrostomy are classified as the pull and introducer methods. Peristomal infection is the most common procedure-related complication in the pull method.

Objectives

The objective of this study was to compare procedure-related complications between the two methods and to assess the outcome of long-term use of the introducer method.

Methods

Between January 1999 and November 2009, 116 patients received percutaneous endoscopic gastrostomy at Seoul St. Mary’s Hospital in Korea. Before June 2006, the pull method was used for all patients; since then, every patient had been treated using the introducer method. We compared outcomes and complications within 180 days of gastrostomy placement for the two methods.

Results

The pull method was performed on 63 patients and the introducer method on 53 patients. The occurrence of peristomal infection within 30 days was significantly lower in the introducer method group than in the pull method group (1.9% vs. 36.5%, P = 0.001). Methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae were the major organisms isolated from the peristomal infection. The requirement for catheter reinsertion because of displacement, obstruction, or damage to the catheter between 30 and 180 days was significantly higher in the introducer method group than in the pull method group (40.5% vs. 0%, P = 0.001).

Conclusions

Our results suggest the superiority of the introducer method in terms of infection control. However, the balloon-type catheter is associated with problems such as balloon insufficiency in long-term use.
Literatur
1.
Zurück zum Zitat Gauderer MW, Ponsky JL, Izant RJ Jr. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg. 1980;15:872–875.PubMedCrossRef Gauderer MW, Ponsky JL, Izant RJ Jr. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg. 1980;15:872–875.PubMedCrossRef
2.
Zurück zum Zitat Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med. 1987;107:824–828.PubMed Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med. 1987;107:824–828.PubMed
3.
Zurück zum Zitat Jonas SK, Neimark S, Panwalker AP. Effect of antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol. 1985;80:438–441.PubMed Jonas SK, Neimark S, Panwalker AP. Effect of antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol. 1985;80:438–441.PubMed
4.
Zurück zum Zitat Schapiro GD, Edmundowicz SA. Complications of percutaneous endoscopic gastrostomy. Gastrointest Endosc Clin N Am. 1996;6:409–422.PubMed Schapiro GD, Edmundowicz SA. Complications of percutaneous endoscopic gastrostomy. Gastrointest Endosc Clin N Am. 1996;6:409–422.PubMed
5.
Zurück zum Zitat McClave SA, Chang WK. Complications of enteral access. Gastrointest Endosc. 2003;58:739–751.PubMedCrossRef McClave SA, Chang WK. Complications of enteral access. Gastrointest Endosc. 2003;58:739–751.PubMedCrossRef
6.
Zurück zum Zitat Sharma VK, Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol. 2000;95:3133–3136.PubMedCrossRef Sharma VK, Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol. 2000;95:3133–3136.PubMedCrossRef
7.
Zurück zum Zitat Rey JR, Axon A, Budzynska A, Kruse A, Nowak A. Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) antibiotic prophylaxis for gastrointestinal endoscopy. European Society of Gastrointestinal Endoscopy. Endoscopy. 1998;30:318–324.PubMedCrossRef Rey JR, Axon A, Budzynska A, Kruse A, Nowak A. Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) antibiotic prophylaxis for gastrointestinal endoscopy. European Society of Gastrointestinal Endoscopy. Endoscopy. 1998;30:318–324.PubMedCrossRef
8.
Zurück zum Zitat American Society for Gastrointestinal Endoscopy. Infection control during gastrointestinal endoscopy: guidelines for clinical application. From the ASGE. Gastrointest Endosc. 1999;49:836–841.CrossRef American Society for Gastrointestinal Endoscopy. Infection control during gastrointestinal endoscopy: guidelines for clinical application. From the ASGE. Gastrointest Endosc. 1999;49:836–841.CrossRef
9.
Zurück zum Zitat Horiuchi A, Nakayama Y, Tanaka N, Fujii H, Kajiyama M. Prospective randomized trial comparing the direct method using a 24 Fr bumper-button-type device with the pull method for percutaneous endoscopic gastrostomy. Endoscopy. 2008;40:722–726.PubMedCrossRef Horiuchi A, Nakayama Y, Tanaka N, Fujii H, Kajiyama M. Prospective randomized trial comparing the direct method using a 24 Fr bumper-button-type device with the pull method for percutaneous endoscopic gastrostomy. Endoscopy. 2008;40:722–726.PubMedCrossRef
10.
Zurück zum Zitat Maetani I, Tada T, Ukita T, Inoue H, Sakai Y, Yoshikawa M. PEG with introducer or pull method: a prospective randomized comparison. Gastrointest Endosc. 2003;57:837–841.PubMedCrossRef Maetani I, Tada T, Ukita T, Inoue H, Sakai Y, Yoshikawa M. PEG with introducer or pull method: a prospective randomized comparison. Gastrointest Endosc. 2003;57:837–841.PubMedCrossRef
11.
Zurück zum Zitat You CR, Kim SW, Paik CN, et al. A risk factor for wound infection after percutaneous endoscopic gastrostomy: decreased performance status. Korean J Gastrointest Endosc. 2007;35:133–139. You CR, Kim SW, Paik CN, et al. A risk factor for wound infection after percutaneous endoscopic gastrostomy: decreased performance status. Korean J Gastrointest Endosc. 2007;35:133–139.
12.
Zurück zum Zitat Horiuchi A, Nakayama Y, Kajiyama M, Fujii H, Tanaka N. Nasopharyngeal decolonization of methicillin-resistant Staphylococcus aureus can reduce peristomal wound infection. Am J Gastroenterol. 2006;101:274–277.PubMedCrossRef Horiuchi A, Nakayama Y, Kajiyama M, Fujii H, Tanaka N. Nasopharyngeal decolonization of methicillin-resistant Staphylococcus aureus can reduce peristomal wound infection. Am J Gastroenterol. 2006;101:274–277.PubMedCrossRef
13.
Zurück zum Zitat Pien EC, Hume KE, Pien FD. Gastrostomy tube infections in a community hospital. Am J Infect Control. 1996;24:353–358.PubMedCrossRef Pien EC, Hume KE, Pien FD. Gastrostomy tube infections in a community hospital. Am J Infect Control. 1996;24:353–358.PubMedCrossRef
14.
Zurück zum Zitat Nunley D, Berk SL. Percutaneous endoscopic gastrostomy as an unrecognized source of methicillin-resistant Staphylococcus aureus colonization. Am J Gastroenterol. 1992;87:58–61.PubMed Nunley D, Berk SL. Percutaneous endoscopic gastrostomy as an unrecognized source of methicillin-resistant Staphylococcus aureus colonization. Am J Gastroenterol. 1992;87:58–61.PubMed
15.
Zurück zum Zitat Chaudhary KA, Smith OJ, Cuddy PG, Clarkston WK. PEG site infections: the emergence of methicillin-resistant Staphylococcus aureus as a major pathogen. Am J Gastroenterol. 2002;97:1713–1716.PubMedCrossRef Chaudhary KA, Smith OJ, Cuddy PG, Clarkston WK. PEG site infections: the emergence of methicillin-resistant Staphylococcus aureus as a major pathogen. Am J Gastroenterol. 2002;97:1713–1716.PubMedCrossRef
16.
Zurück zum Zitat Hull M, Beane A, Bowen J, Settle C. Methicillin-resistant Staphylococcus aureus infection of percutaneous endoscopic gastrostomy sites. Aliment Pharmacol Ther. 2001;15:1883–1888.PubMedCrossRef Hull M, Beane A, Bowen J, Settle C. Methicillin-resistant Staphylococcus aureus infection of percutaneous endoscopic gastrostomy sites. Aliment Pharmacol Ther. 2001;15:1883–1888.PubMedCrossRef
17.
Zurück zum Zitat Faias S, Cravo M, Claro I, Lage P, Nobre-Leitão C. High rate of percutaneous endoscopic gastrostomy site infections due to oropharyngeal colonization. Dig Dis Sci. 2006;51:2384–2388.PubMedCrossRef Faias S, Cravo M, Claro I, Lage P, Nobre-Leitão C. High rate of percutaneous endoscopic gastrostomy site infections due to oropharyngeal colonization. Dig Dis Sci. 2006;51:2384–2388.PubMedCrossRef
18.
Zurück zum Zitat Thomas S, Cantrill S, Waghorn DJ, McIntyre A. The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus. Aliment Pharmacol Ther. 2007;25:593–597.PubMedCrossRef Thomas S, Cantrill S, Waghorn DJ, McIntyre A. The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus. Aliment Pharmacol Ther. 2007;25:593–597.PubMedCrossRef
19.
Zurück zum Zitat Russell TR, Brotman M, Norris F. Percutaneous gastrostomy. A new simplified and cost-effective technique. Am J Surg. 1984;148:132–137.PubMedCrossRef Russell TR, Brotman M, Norris F. Percutaneous gastrostomy. A new simplified and cost-effective technique. Am J Surg. 1984;148:132–137.PubMedCrossRef
20.
Zurück zum Zitat Deitel M, Bendago M, Spratt EH, Burul CJ, To TB. Percutaneous endoscopic gastrostomy by the “pull” and “introducer” methods. Can J Surg. 1988;31:102–104.PubMed Deitel M, Bendago M, Spratt EH, Burul CJ, To TB. Percutaneous endoscopic gastrostomy by the “pull” and “introducer” methods. Can J Surg. 1988;31:102–104.PubMed
21.
Zurück zum Zitat Toyama Y, Usuba T, Son K, et al. Successful new method of extracorporeal percutaneous endoscopic gastrostomy (E-PEG). Surg Endosc. 2007;21:2034–2038.PubMedCrossRef Toyama Y, Usuba T, Son K, et al. Successful new method of extracorporeal percutaneous endoscopic gastrostomy (E-PEG). Surg Endosc. 2007;21:2034–2038.PubMedCrossRef
22.
Zurück zum Zitat Hiki N, Maetani I, Suzuki Y, et al. Reduced risk of peristomal infection of direct percutaneous endoscopic gastrostomy in cancer patients: comparison with the pull percutaneous endoscopic gastrostomy procedure. J Am Coll Surg. 2008;207:737–744.PubMedCrossRef Hiki N, Maetani I, Suzuki Y, et al. Reduced risk of peristomal infection of direct percutaneous endoscopic gastrostomy in cancer patients: comparison with the pull percutaneous endoscopic gastrostomy procedure. J Am Coll Surg. 2008;207:737–744.PubMedCrossRef
23.
Zurück zum Zitat Shastri YM, Hoepffner N, Tessmer A, Ackermann H, Schroeder O, Stein J. New introducer PEG gastropexy does not require prophylactic antibiotics: multicenter prospective randomized double-blind placebo-controlled study. Gastrointest Endosc. 2008;67:620–628.PubMedCrossRef Shastri YM, Hoepffner N, Tessmer A, Ackermann H, Schroeder O, Stein J. New introducer PEG gastropexy does not require prophylactic antibiotics: multicenter prospective randomized double-blind placebo-controlled study. Gastrointest Endosc. 2008;67:620–628.PubMedCrossRef
24.
Zurück zum Zitat Higaki F, Yokota O, Ohishi M. Factors predictive of survival after percutaneous endoscopic gastrostomy in the elderly: is dementia really a risk factor? Am J Gastroenterol. 2008;103:1011–1016.PubMedCrossRef Higaki F, Yokota O, Ohishi M. Factors predictive of survival after percutaneous endoscopic gastrostomy in the elderly: is dementia really a risk factor? Am J Gastroenterol. 2008;103:1011–1016.PubMedCrossRef
25.
Zurück zum Zitat Tominaga N, Shimoda R, Iwakiri R, et al. Low serum albumin level is risk factor for patients with percutaneous endoscopic gastrostomy. Intern Med. 2010;49:2283–2288.PubMedCrossRef Tominaga N, Shimoda R, Iwakiri R, et al. Low serum albumin level is risk factor for patients with percutaneous endoscopic gastrostomy. Intern Med. 2010;49:2283–2288.PubMedCrossRef
Metadaten
Titel
Successful Control of Peristomal Infection by Introducer-Type Percutaneous Endoscopic Gastrostomy: A Retrospective Historical Control Study
verfasst von
Chul-Hyun Lim
Jae Myung Park
Yu Kyung Cho
In Seok Lee
Sang Woo Kim
Myung-Gyu Choi
In-Sik Chung
Publikationsdatum
01.07.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1570-9

Weitere Artikel der Ausgabe 7/2011

Digestive Diseases and Sciences 7/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.